Walgreens Launches Major Expansion in Specialty Pharmacy with Gene and Cell Services

Walgreens introduces a comprehensive suite of gene and cell therapy services, aiming to enhance patient care and streamline treatment processes.

Walgreens Specialty Pharmacy, a $24 billion initiative, integrates gene and cell services with existing pharmacy assets to address complex health conditions.
The expansion includes a new 18,000-square-foot innovation center in Pittsburgh, dedicated to managing the complexities of gene and cell therapy treatments.
Walgreens aims to bolster patient outcomes by working directly with drugmakers and ensuring swift access to specialized medications across nearly 300 community-based pharmacies.
The company's specialty pharmacy services are expected to drive significant cost efficiencies and improve care coordination across healthcare stakeholders.
Walgreens maintains its position as the largest independent provider of specialty pharmacy services, not aligned with any pharmacy benefit manager.